Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Frontotemporal dementia (FTD) is the second most common cause of dementia in people under the age of 65 years. A large proportion of FTD patients (35-50%) have a family history of dementia, consistent with a strong genetic component to the disease. In 1998, mutations in the gene encoding the microtubule-associated protein tau (MAPT) were shown to cause familial FTD with parkinsonism linked to chromosome 17q21 (FTDP-17). The neuropathology of patients with defined MAPT mutations is characterized by cytoplasmic neurofibrillary inclusions composed of hyperphosphorylated tau. However, in multiple FTD families with significant evidence for linkage to the same region on chromosome 17q21 (D17S1787-D17S806), mutations in MAPT have not been found and the patients consistently lack tau-immunoreactive inclusion pathology. In contrast, these patients have ubiquitin (ub)-immunoreactive neuronal cytoplasmic inclusions and characteristic lentiform ub-immunoreactive neuronal intranuclear inclusions. Here we demonstrate that in these families, FTD is caused by mutations in progranulin (PGRN) that are likely to create null alleles. PGRN is located 1.7 Mb centromeric of MAPT on chromosome 17q21.31 and encodes a 68.5-kDa secreted growth factor involved in the regulation of multiple processes including development, wound repair and inflammation. PGRN has also been strongly linked to tumorigenesis. Moreover, PGRN expression is increased in activated microglia in many neurodegenerative diseases including Creutzfeldt-Jakob disease, motor neuron disease and Alzheimer's disease. Our results identify mutations in PGRN as a cause of neurodegenerative disease and indicate the importance of PGRN function for neuronal survival.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“has been implicated in frontotemporal dementia in humans and mice”
From Cross-Species Single-Cell Analysis Reveals Divergence of the Primate Microglia Program (2019) · cites this paper as Baker et al., 2006
In the citing paper
“Importantly, while abnormal proteostasis is a hallmark of aging and misfolded proteins are a key feature in both LSDs and neurodegeneration, other macromolecules are processed by the lysosome, evidenced by the finding that both lipid and carbohydrate metabolism are disrupted in these diseases throughout the lifespan.12,13”
From The lysosome and proteostatic stress at the intersection of pediatric neurological disorders and adult neurodegenerative diseases (2025) · cites this paper as [12]
In the citing paper
“Haploinsufficiency of GRN is also associated with frontotemporal lobar degeneration34.”
From Rare variant associations with plasma protein levels in the UK Biobank (2023) · cites this paper as [34]
In the citing paper
“We also identified two lysosomal proteins, GRN and TMEM106B80,81, that are associated with frontotemporal dementia (FTD)82,83 but were also identified in the latest AD risk GWAS23.”
From Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and implicates causal proteins for Alzheimer’s disease (2024) · cites this paper as [83]
In the citing paper
“The most common genes linked to familial FTD are MAPT, progranulin (GRN), and chromosome 9 open reading frame 72 (C9orf72).”
From New developments of biofluid‐based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia (2022) · cites this paper as [37]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498 · cited 1×
“These include the mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3-OH kinase (PI(3)K) cascades(14,28), both of which regulate crucial functions in neurons.”
BackgroundSelf-citationCruts, M., Gijselinck, I., van der Zee, J., Engelborghs, S., Wils, H., Pirici, D., Rademakers, R., Vandenberghe, R., Dermaut, B., Martin, J.-J., et al. (2006) · Nature · doi:10.1038/nature05017 · Cited by 1,512
Self-citationClinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups.
(1994) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.4.416 · Cited by 1,331
Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics
Maquat, L. E. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1310 · Cited by 1,214
ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis
Greenway, M. J., Andersen, P. M., Russ, C., Ennis, S., Cashman, S., Donaghy, C., Patterson, V., Swingler, R., Kieran, D., Prehn, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1742 · Cited by 667
Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference
Foster, N. L., Wilhelmsen, K., Sima, A. A. F., Jones, M. Z., D'Amato, C. J., Gilman, S., & Participants, C. (1997) · Annals of Neurology · doi:10.1002/ana.410410606 · Cited by 634
Progranulin is a mediator of the wound response
He, Z., Ong, C. H. P., Halper, J., & Bateman, A. (2003) · Nature Medicine · doi:10.1038/nm816 · Cited by 490
He, Z., & Bateman, A. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0474-3 · Cited by 476
Cellular Localization of Gene Expression for Progranulin
Daniel, R., He, Z., Carmichael, K. P., Halper, J., & Bateman, A. (2000) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540004800713 · Cited by 346
Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice
Capsoni, S., Ugolini, G., Comparini, A., Ruberti, F., Berardi, N., & Cattaneo, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.12.6826 · Cited by 277
Research works printed but not linked: 1
- Froelich, S. et al. Mapping of a disease locus for familial rapidly progressive frontotemporal dementia to chromosome 17q12–21. Am. J. Med. Genet. 74, 380–385 (1997) · doi:10.1002/(sici)1096-8628(19970725)74:4<380::aid-ajmg8>3.0.co;2-t
Cited by
Items 701–800 of 1,018
A changing landscape for advance directives in dementia research
Pierce, R. L. (2009) · Social Science & Medicine · doi:10.1016/j.socscimed.2009.10.037 · Cited by 54
New Perspective on Parkinsonism in Frontotemporal Lobar Degeneration
Park, H. K., & Chung, S. J. (2013) · Journal of Movement Disorders · doi:10.14802/jmd.13001 · Cited by 49
Ma, Y., Matsuwaki, T., Yamanouchi, K., & Nishihara, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9939-6 · Cited by 53
Prion‐like propagation as a pathogenic principle in frontotemporal dementia
Hock, E., & Polymenidou, M. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13668 · Cited by 65
Sleat, D. E., Gedvilaite, E., Zhang, Y., Lobel, P., & Xing, J. (2016) · Gene · doi:10.1016/j.gene.2016.08.031 · Cited by 51
Sassi, C., Nalls, M. A., Ridge, P. G., Gibbs, J. R., Lupton, M. K., Troakes, C., Lunnon, K., Al-Sarraj, S., Brown, K. S., Medway, C., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.01.015 · Cited by 50
Self-citationMapping the progression of progranulin-associated frontotemporal lobar degeneration
Rohrer, J. D., Warren, J. D., Barnes, J., Mead, S., Beck, J., Pepple, T., Boyes, R., Omar, R., Collinge, J., Stevens, J. M., et al. (2008) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0869 · Cited by 49
Progressive Nonfluent Aphasia Associated With a New Mutation V363I in Tau Gene
Munoz, D. G., Ros, R., Fatas, M., Bermejo, F., & de Yebenes, J. G. (2007) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317507302320 · Cited by 50
Activity-dependent secretion of progranulin from synapses
Petoukhov, E., Fernando, S., Mills, F., Shivji, F., Hunter, D., Krieger, C., Silverman, M. A., & Bamji, S. X. (2013) · Journal of Cell Science · doi:10.1242/jcs.132076 · Cited by 50
Rollinson, S. J., Mead, S., Snowden, J. S., Richardson, A. M. T., Rohrer, J. D., Halliwell, N. A., Usher, S., Neary, D., Mann, D. M. A., Hardy, J., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.12.005 · Cited by 50
Self-citationBigio, E. H., Weıntraub, S., Rademakers, R., Baker, M. C., Ahmadian, S. S., RADEMAKER, A. W., Weitner, B. B., Mao, Q., Lee, K. ‐., Mishra, M., et al. (2012) · Neuropathology · doi:10.1111/j.1440-1789.2012.01332.x · Cited by 47
Self-citationHargus, G., Ehrlich, M., Hallmann, A.-L., & Kuhlmann, T. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1222-6 · Cited by 60
Development of macrophages of cyprinid fish
Hanington, P. C., Tam, J., Katzenback, B. A., Hitchen, S. J., Barreda, D. R., & Belosevic, M. (2008) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2008.11.004 · Cited by 53
Zhao, Y., Liu, B., & Liu, C.-J. (2014) · Journal of Visualized Experiments · doi:10.3791/50924 · Cited by 50
Progranulin Protein Levels in Cerebrospinal Fluid in Primary Neurodegenerative Dementias
Morenas-Rodríguez, E., Cervera-Carles, L., Vilaplana, E., Alcolea, D., Carmona-Iragui, M., Dols-Icardo, O., Ribosa-Nogué, R., Muñoz-Llahuna, L., Sala, I., Belén Sánchez-Saudinós, M., et al. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150746 · Cited by 49
Zhou, X., Sun, L., Brady, O. A., Murphy, K. A., & Hu, F. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0412-1 · Cited by 49
Mohan, S., Sampognaro, P. J., Argouarch, A. R., Maynard, J. C., Welch, M., Patwardhan, A., Courtney, E. C., Zhang, J., Mason, A., Li, K. H., et al. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00472-1 · Cited by 49
Primary Progressive Aphasia and Alzheimer’s Disease: Brief History, Recent Evidence
Kirshner, H. S. (2012) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-012-0307-2 · Cited by 58
Sex differences in the genetic architecture of Alzheimer’s disease
Dumitrescu, L., Mayeda, E. R., Sharman, K., Moore, A. M., & Hohman, T. J. (2019) · Current Genetic Medicine Reports · doi:10.1007/s40142-019-0157-1 · Cited by 48
Genetics of dementia: Update and guidelines for the clinician
Cohn‐Hokke, P. E., Elting, M. W., Pijnenburg, Y. A. L., & van Swieten, J. C. (2012) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32080 · Cited by 48
Neuropathology of frontotemporal lobar degeneration: A review
Bahia, V. S., Takada, L. T., & Deramecourt, V. (2013) · Dementia & Neuropsychologia · doi:10.1590/s1980-57642013dn70100004 · Cited by 48
No association of PGRN 3′UTR rs5848 in frontotemporal lobar degeneration
Rollinson, S. J., Rohrer, J. D., van der Zee, J., Sleegers, K., Mead, S., Engelborghs, S., Collinge, J., Deyn, P. P. D., Mann, D. M. A., Broeckhoven, C. V., et al. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.04.009 · Cited by 48
Self-citationTDP-43 in neurodegenerative disorders
Cook, C., Zhang, Y.-J., Xu, Y.-F., Dickson, D. W., & Petrucelli, L. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.7.969 · Cited by 48
Self-citationEffect ofTMEM106BPolymorphism on Functional Network Connectivity in AsymptomaticGRNMutation Carriers
Premi, E., Formenti, A., Gazzina, S., Archetti, S., Gasparotti, R., Padovani, A., & Borroni, B. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.4835 · Cited by 54
Genetic and neuroanatomic associations in sporadic frontotemporal lobar degeneration
McMillan, C. T., Toledo, J. B., Avants, B. B., Cook, P. A., Wood, E. M., Suh, E., Irwin, D. J., Powers, J., Olm, C., Elman, L., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.11.029 · Cited by 48
Busch, J. I., Martinez-Lage, M., Ashbridge, E., Grossman, M., Van Deerlin, V. M., Hu, F., Lee, V. M., Trojanowski, J. Q., & Chen-Plotkin, A. S. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-36 · Cited by 48
Gray matter changes in asymptomatic C9orf72 and GRN mutation carriers
Popuri, K., Dowds, E., Beg, M. F., Balachandar, R., Bhalla, M., Jacova, C., Buller, A., Slack, P., Sengdy, P., Rademakers, R., et al. (2018) · NeuroImage Clinical · doi:10.1016/j.nicl.2018.02.017 · Cited by 59
Self-citationPalese, F., Bonomi, E., Nuzzo, T., Benussi, A., Mellone, M., Zianni, E., Cisani, F., Casamassa, A., Alberici, A., Scheggia, D., et al. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.10.015 · Cited by 54
Courtland, J. L., Bradshaw, T. W., Waitt, G., Soderblom, E. J., Ho, T., Rajab, A., Vancini, R., Kim, I. H., & Soderling, S. H. (2021) · eLife · doi:10.7554/elife.61590 · Cited by 49
Tweaking Progranulin Expression: Therapeutic Avenues and Opportunities
Terryn, J., Verfaillie, C. M., & Damme, P. V. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.713031 · Cited by 48
Roles of Progranulin in Sexual Differentiation of the Developing Brain and Adult Neurogenesis
SUZUKI, M., LEE, H.-C., KAYASUGA, Y., CHIBA, S., NEDACHI, T., MATSUWAKI, T., YAMANOUCHI, K., & NISHIHARA, M. (2009) · Journal of Reproduction and Development · doi:10.1262/jrd.20249 · Cited by 48
Genetics of Gene Expression in the Aging Human Brain Reveal TDP-43 Proteinopathy Pathophysiology
Yang, H.-S., White, C. C., Klein, H.-U., Yu, L., Gaiteri, C., Ma, Y., Felsky, D., Mostafavi, S., Petyuk, V. A., Sperling, R. A., et al. (2020) · Neuron · doi:10.1016/j.neuron.2020.05.010 · Cited by 47
Regulation of lysosomal trafficking of progranulin by sortilin and prosaposin
Du, H., Zhou, X., Feng, T., & Hu, F. (2022) · Brain Communications · doi:10.1093/braincomms/fcab310 · Cited by 47
Li, M.-L., Liu, Y., Xia, F., Wu, Z., Deng, L., Jiang, R., & Guo, F. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.03.026 · Cited by 51
Inflammation and clinical presentation in neurodegenerative disease: a volatile relationship
Bettcher, B. M., & Kramer, J. H. (2013) · Neurocase · doi:10.1080/13554794.2011.654227 · Cited by 47
Linking RNA Dysfunction and Neurodegeneration in Amyotrophic Lateral Sclerosis
Barmada, S. J. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0340-3 · Cited by 56
Corticospinal tract degeneration associated with TDP-43 type C pathology and semantic dementia
Josephs, K. A., Whitwell, J. L., Murray, M. E., Parisi, J. E., Graff-Radford, N. R., Knopman, D. S., Boeve, B. F., Senjem, M. L., Rademakers, R., Jack, C. R., et al. (2013) · Brain · doi:10.1093/brain/aws324 · Cited by 47
Self-citationYu, Y., Xu, X., Liu, L., Mao, S., Feng, T., Lu, Y., Cheng, Y., Wang, H., Zhao, W., & Tang, W. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12756 · Cited by 53
Van Kampen, J. M., & Kay, D. G. (2017) · PLOS ONE · doi:10.1371/journal.pone.0182896 · Cited by 47
Genetics and dementia: Risk factors, diagnosis, and management
Hsiung, G. R., & Dessa Sadovnick, A. (2007) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2007.07.010 · Cited by 47
Self-citationEvidence for linkage of restless legs syndrome to chromosome 9p: Are there two distinct loci?
Lohmann-Hedrich, K., Neumann, A., Kleensang, A., Lohnau, T., Muhle, H., Djarmati, A., König, I. R., Pramstaller, P. P., SCHWINGER, E., Kramer, P. L., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000282760.07650.ba · Cited by 47
Heuer, H. W., Wang, P., Rascovsky, K., Wolf, A., Appleby, B., Bove, J., Bordelon, Y., Brannelly, P., Brushaber, D. E., Caso, C., et al. (2020) · Alzheimer's & Dementia · doi:10.1002/alz.12046 · Cited by 43
Self-citationWilke, C., Reich, S., van Swieten, J. C., Borroni, B., Sanchez‐Valle, R., Moreno, F., Laforce, R., Graff, C., Galimberti, D., Rowe, J. B., et al. (2022) · Annals of Neurology · doi:10.1002/ana.26265 · Cited by 46
TMEM106B aggregation in neurodegenerative diseases: linking genetics to function
Jiao, H.-S., Yuan, P., & Yu, J.-T. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00644-1 · Cited by 46
The endolysosomal pathway and ALS/FTD
Todd, T. W., Shao, W., Zhang, Y., & Petrucelli, L. (2023) · Trends in Neurosciences · doi:10.1016/j.tins.2023.09.004 · Cited by 47
Cerebrospinal Fluid Biomarkers in Progranulin Mutations Carriers
Carecchio, M., Fenoglio, C., Cortini, F., Comi, C., Benussi, L., Ghidoni, R., Borroni, B., De Riz, M., Serpente, M., Cantoni, C., et al. (2011) · Journal of Alzheimer’s Disease · doi:10.3233/jad-2011-111046 · Cited by 46
Yeh, H. H., Young, D. P., Gelovani, J. G., Robinson, A., Davidson, Y. S., Herholz, K., & Mann, D. M. A. (2013) · Brain Research · doi:10.1016/j.brainres.2013.02.012 · Cited by 50
Self-citationRossi, G., Bastone, A., Piccoli, E., Mazzoleni, G., Morbin, M., Uggetti, A., Giaccone, G., Sperber, S. A., Beeg, M., Salmona, M., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.08.008 · Cited by 53
Age-Dependent Changes in Progranulin Expression in the Mouse Brain
Matsuwaki, T., Asakura, R., Suzuki, M., Yamanouchi, K., & Nishihara, M. (2010) · Journal of Reproduction and Development · doi:10.1262/jrd.10-116s · Cited by 50
Targeting angiogenin in therapy of amyotropic lateral sclerosis
Kishikawa, H., Wu, D., & Hu, G.-F. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.10.1229 · Cited by 52
New discovery rarely runs smooth: an update on progranulin/TNFR interactions
Wang, B. C., Liu, H. W., Talwar, A. A., & Jian, J. (2015) · Protein & Cell · doi:10.1007/s13238-015-0213-x · Cited by 51
The role of CHMP2BIntron5 in autophagy and frontotemporal dementia
Krasniak, C. S., & Ahmad, S. T. (2016) · Brain Research · doi:10.1016/j.brainres.2016.02.051 · Cited by 52
Genetic architecture of common non-Alzheimer’s disease dementias
Guerreiro, R. J., Gibbons, E., Tábuas‐Pereira, M., Kun‐Rodrigues, C., Cordeiro, G., & Brás, J. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104946 · Cited by 51
Harnessing Immunoproteostasis to Treat Neurodegenerative Disorders
Golde, T. E. (2019) · Neuron · doi:10.1016/j.neuron.2019.02.027 · Cited by 45
Hasan, R., Humphrey, J., Bettencourt, C., Newcombe, J., Lashley, T., Fratta, P., & Raj, T. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02399-9 · Cited by 53
Hasan, S., Fernandopulle, M. S., Humble, S. W., Frankenfield, A. M., Li, H., Prestil, R., Johnson, K. R., Ryan, B. J., Wade‐Martins, R., Ward, M. E., et al. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00673-w · Cited by 55
Progranulin (GRN)in two siblings of a Latino family and in other patients with Schizophrenia
Momeni, P., DeTucci, K., Straub, R. E., Weinberger, D. R., Davies, P., Grafman, J., Hardy, J., & Huey, E. D. (2010) · Neurocase · doi:10.1080/13554790903456209 · Cited by 45
Epidemiology and genetics of frontotemporal dementia: a door-to-door survey in Southern Italy
Bernardi, L., Frangipane, F., Smirne, N., Colao, R., Puccio, G., Curcio, S. A. M., Mirabelli, M., Maletta, R., Anfossi, M., Gallo, M., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.06.017 · Cited by 53
Thurner, L., Zaks, M., Preuss, K., Fadle, N., Regitz, E., Ong, M. F., Pfreundschuh, M. G., & Assmann, G. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4406 · Cited by 44
Uesaka, N., Abe, M., Konno, K., Yamazaki, M., Sakoori, K., Watanabe, T., Kao, T., Mikuni, T., Watanabe, M., Sakimura, K., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.01.018 · Cited by 49
Pinarbasi, E. S., Karamyshev, A. L., Tikhonova, E. B., Wu, I.-H., Hudson, H., & Thomas, P. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.003 · Cited by 46
Marsan, E., Velmeshev, D., Ramsey, A., Patel, R. K., Zhang, J., Koontz, M., Andrews, M. G., de Majo, M., Mora, C., Blumenfeld, J., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci164919 · Cited by 45
“Interestingly, although GRN RNA was detected in the hTH and hFCX of patients with FTLDGRN, because these were nuclear transcripts not subject to nonsense-mediated decay in the cytoplasm (14), immunostains using PGRN-specific abs showed a marked reduction of PGRN proteins (Figure 3, F–H), supporting a drastic loss of P…”
BackgroundGenetic risk factors for Alzheimer disease: emerging roles of microglia in disease pathomechanisms
Takatori, S., Wang, W., Iguchi, A., & Tomita, T. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-05542-4_5 · Cited by 44
Glycosphingolipid metabolism and its role in ageing and Parkinson’s disease
Wallom, K., Fernández‐Suárez, M. E., Priestman, D. A., Vruchte, D. T., Huebecker, M., Hallett, P. J., Isacson, O., & Platt, F. M. (2021) · Glycoconjugate Journal · doi:10.1007/s10719-021-10023-x · Cited by 47
Granulin loss of function in human mature brain organoids implicates astrocytes in TDP-43 pathology
de Majo, M., Koontz, M., Marsan, E., Salinas, N., Ramsey, A., Kuo, Y.-M., Seo, K., Li, H., Dräger, N., Leng, K., et al. (2023) · Stem Cell Reports · doi:10.1016/j.stemcr.2023.01.012 · Cited by 44
Plasma levels of progranulin and interleukin-6 in frontotemporal lobar degeneration
Gibbons, L., Rollinson, S., Thompson, J. C., Robinson, A., Davidson, Y. S., Richardson, A., Neary, D., Pickering-Brown, S. M., Snowden, J. S., & Mann, D. M. A. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.10.023 · Cited by 44
Self-citationKim, E., Kwon, J. C., Park, K. H., Park, K.-W., Lee, J., Choi, S. H., Jeong, J. H., Kim, B. C., Yoon, S. J., Yoon, Y. C., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.11.033 · Cited by 49
Genetics of frontotemporal lobar degeneration: An up-date and diagnosis algorithm
Ber, I. L. (2013) · Revue Neurologique · doi:10.1016/j.neurol.2013.07.014 · Cited by 56
Zhou, X., Sullivan, P. M., Sun, L., & Hu, F. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14110 · Cited by 44
Neuroinflammation in Amyotrophic Lateral Sclerosis: Role of Redox (dys)Regulation
D’Ambrosi, N., Cozzolino, M., & Carrì, M. T. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7271 · Cited by 47
Tann, J. Y., Wong, L., Sajikumar, S., & Ibáñez, C. F. (2019) · The EMBO Journal · doi:10.15252/embj.2018100989 · Cited by 47
Sellami, L., Rucheton, B., Benyounes, I., Camuzat, A., Saracino, D., Rinaldi, D., Epelbaum, S., Azuar, C., Lévy, R., Auriacombe, S., et al. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.02.014 · Cited by 50
Neuroimaging in genetic frontotemporal dementia and amyotrophic lateral sclerosis
Häkkinen, S., Chu, S. A., & Lee, S. E. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105063 · Cited by 43
Neuronal VCP loss of function recapitulates FTLD-TDP pathology
Wani, A., Zhu, J., Ulrich, J. D., Eteleeb, A. M., Sauerbeck, A. D., Reitz, S. J., Arhzaouy, K., Ikenaga, C., Yuede, C. M., Pittman, S. K., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109399 · Cited by 46
TDP-43 gene analysis in frontotemporal lobar degeneration
Rollinson, S. J., Snowden, J. S., Neary, D., Morrison, K. E., Mann, D. M. A., & Pickering-Brown, S. M. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.03.044 · Cited by 44
Self-citationWider, C., & Wszolek, Z. K. (2008) · Neurodegenerative Diseases · doi:10.1159/000113680 · Cited by 44
Knibb, J. A., Kipps, C. M., & Hodges, J. R. (2006) · Current Opinion in Neurology · doi:10.1097/01.wco.0000247606.57567.41 · Cited by 44
Goossens, J., Vanmechelen, E., Trojanowski, J. Q., Lee, V. M., Van Broeckhoven, C., van der Zee, J., & Engelborghs, S. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0195-1 · Cited by 43
RNA Binding Proteins and the Pathogenesis of Frontotemporal Lobar Degeneration
Hofmann, J. W., Seeley, W. W., & Huang, E. J. (2019) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012955 · Cited by 47
Neuronal ceroid lipofuscinosis type-11 in an adolescent
Kamate, M., Detroja, M., & Hattiholi, V. V. (2019) · Brain and Development · doi:10.1016/j.braindev.2019.03.004 · Cited by 46
Role of MAPT mutations and haplotype in frontotemporal lobar degeneration in Northern Finland
Kaivorinne, A.-L., Krüger, J., Kuivaniemi, K., Tuominen, H., Moilanen, V., Majamaa, K., & Remes, A. M. (2008) · BMC Neurology · doi:10.1186/1471-2377-8-48 · Cited by 43
Biomarkers in frontotemporal lobar degenerations—Progress and challenges
Hu, W. T., Trojanowski, J. Q., & Shaw, L. M. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.04.012 · Cited by 42
“(Baker et al., 2006; Gass et al., 2006) In familial FTLD cases with PGRN mutations, plasma progranulin levels were decreased compared to control subjects.”
BackgroundFrequency of C9orf72 repeat expansions in amyotrophic lateral sclerosis: a Belgian cohort study
Debray, S., Race, V., Crabbé, V., Herdewyn, S., Matthijs, G., Goris, A., Dubois, B., Thijs, V., Robberecht, W., & Damme, P. V. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.06.009 · Cited by 45
Initiation and propagation of neurodegeneration
Haass, C. (2010) · Nature Medicine · doi:10.1038/nm.2223 · Cited by 50
Butler, V. J., Cortopassi, W. A., Gururaj, S., Wang, A. L., Pierce, O. M., Jacobson, M. P., & Kao, A. W. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00275 · Cited by 42
Miller, B. L., & Guerra, J. J. L. (2019) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64012-3.00003-4 · Cited by 56
Lladó, A., Sánchez‐Valle, R., Rey, M. J., Ezquerra, M., TOLOSA, E. S., Ferrer, I., Molinuevo, J. L., & for the Catalan collaborative Study Group for FTLD* (2008) · Journal of Neurology · doi:10.1007/s00415-008-0565-8 · Cited by 43
Songsrirote, K., Li, Z., Ashford, D. A., Bateman, A., & THOMAS‐OATES, J. E. (2010) · Journal of Proteomics · doi:10.1016/j.jprot.2010.02.013 · Cited by 44
Progranulin (PGRN) expression in ALS: An immunohistochemical study
Irwin, D. J., Lippa, C. F., & Rosso, A. L. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.08.024 · Cited by 43
Lindquist, S. G., Brændgaard, H., Svenstrup, K., Isaacs, A. M., & Nielsen, J. E. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02144.x · Cited by 44
Sharma, V., Nikolajeff, F. K., & Kumar, S. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00339-z · Cited by 48
Caenorhabditis elegans: A transgenic model for studying age-associated neurodegenerative diseases
Rani, N., Alam, M. M., Jamal, A., Ghaffar, U. B., & Parvez, S. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102036 · Cited by 44
Lashley, T., Rohrer, J. D., Mahoney, C., Gordón, E., Beck, J. A., Mead, S., Warren, J. D., Rossor, M. N., & Révész, T. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12100 · Cited by 48
Closing the tau loop: the missing tau mutation
McCarthy, A., Lonergan, R., Olszewska, D. A., O’Dowd, S., Cummins, G., Magennis, B., Fallon, E. M., Pender, N., Huey, E. D., Cosentino, S., et al. (2015) · Brain · doi:10.1093/brain/awv234 · Cited by 40
Self-citationRossi, G., Bastone, A., Piccoli, E., Morbin, M., Mazzoleni, G., Fugnanesi, V., Beeg, M., Favero, E. D., Cantú, L., Motta, S., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.08.004 · Cited by 45
Devoogdt, N., Rasool, N., Hoskins, E. R., Simpkins, F. A., Tchabo, N. E., & Kohn, E. C. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01076.x · Cited by 41
Molecular Pathways of Frontotemporal Lobar Degeneration
Sleegers, K., Cruts, M., & Broeckhoven, C. V. (2010) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-060909-153144 · Cited by 53
Genetic counseling for FTD/ALS caused by the C9ORF72 hexanucleotide expansion
Fong, J. C., Karydas, A. M., & Goldman, J. S. (2012) · Alzheimer s Research & Therapy · doi:10.1186/alzrt130 · Cited by 47
Asymmetric pathology in primary progressive aphasia with progranulin mutations and TDP inclusions
Kım, G., Ahmadian, S. S., Peterson, M., Parton, Z., Memon, R., Weıntraub, S., RADEMAKER, A. W., Bigio, E. H., Mesulam, M. M., & Geula, C. (2016) · Neurology · doi:10.1212/wnl.0000000000002375 · Cited by 45
Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies
Orme, T., Hernandez, D., Ross, O. A., Kun-Rodrigues, C., Darwent, L., Shepherd, C. E., Parkkinen, L., Ansorge, O., Clark, L., Honig, L. S., et al. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-0879-z · Cited by 41
Self-citation
Metadata
- Authors
- Baker, M., Mackenzie, I. R., Pickering-Brown, S. M., Gass, J., Rademakers, R., Lindholm, C., Snowden, J., Adamson, J., Sadovnick, A. D., Rollinson, S., Cannon, A., Dwosh, E., Neary, D., Melquist, S., Richardson, A., Dickson, D., Berger, Z., Eriksen, J., Robinson, T., Zehr, C., Dickey, C. A., Crook, R., McGowan, E., Mann, D., Boeve, B., Feldman, H., & Hutton, M.
- Affiliations
- Mayo Clinic in Florida (US)
- University of Manchester (GB)
- University of British Columbia (CA)
- Mayo Clinic (US)
- Corresponding author
- Mackenzie, Ian R.
- Hutton, Mike
- ORCID
- Baker, Matt
- Mackenzie, Ian R.
- Pickering-Brown, Stuart M.
- Gass, Jennifer
- Rademakers, Rosa
- Snowden, Julie
- Sadovnick, A. Dessa
- Rollinson, Sara
- Cannon, Ashley
- Dwosh, Emily
- Neary, David
- Melquist, Stacey
- Richardson, Anna
- Dickson, Dennis
- Berger, Zdenek
- Eriksen, Jason
- Dickey, Chad A.
- Crook, Richard
- McGowan, Eileen
- Mann, David
- Boeve, Bradley
- Feldman, Howard
- Venue
- Nature
- Published
- 2006-07-16
- Volume
- 442
- Issue
- 7105
- Pages
- 916-919
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2027460468
- Cited by
- 2,058
- References
- 31
- Citations by year
- 2026: 56 · 2025: 77 · 2024: 102 · 2023: 94 · 2022: 93 · 2021: 115 · 2020: 89 · 2019: 114 · 2018: 88 · 2017: 109 · 2016: 103 · 2015: 81 · 2014: 89 · 2013: 107 · 2012: 110
- FWCI
- 86.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- progranulin, frontotemporal dementia, chromosome 17q21, MAPT, ubiquitin-positive inclusions, neuronal intranuclear inclusions, neurodegeneration, familial dementia, null alleles, growth factors, FTDP-17
- MeSH terms
- Progranulins, Cell Survival, Chromosomes, Human, Pair 17, Dementia, Frontal Lobe, Humans, Genetic Linkage, Mutation, Neurons, Protein Precursors, RNA, Messenger, Temporal Lobe, tau Proteins, Codon, Terminator, Physical Chromosome Mapping, RNA Stability, Intercellular Signaling Peptides and Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.